obstructive sleep
play

OBSTRUCTIVE SLEEP Lapses in Concentration: big increase if 6 hours - PDF document

Chronic Sleep Deprivation (0 v 4 v 6 v 8 hrs) OBSTRUCTIVE SLEEP Lapses in Concentration: big increase if 6 hours (Van Dongen Sleep 2003) APNEA and WORK Treatment Update David Claman, MD Professor of Medicine Director, UCSF Sleep Disorders


  1. Chronic Sleep Deprivation (0 v 4 v 6 v 8 hrs) OBSTRUCTIVE SLEEP Lapses in Concentration: big increase if ≤ 6 hours (Van Dongen Sleep 2003) APNEA and WORK Treatment Update David Claman, MD Professor of Medicine Director, UCSF Sleep Disorders Center 415-885-7886 Disclosures: None 1

  2. DEFINITIONS: CLINICAL PREDICTORS OF OSA u Apnea: complete cessation of airflow lasting 10 second or more • Screening questionnaires u Hypopnea: reduced airflow for 10 seconds or more, • Epworth Sleepiness Scale: range 0-24 for 8 questions associated with 4% oxygen desaturation – Normal score < 10 u 3% is AASM recommendation; 4% is Medicare definition – In OSA population, score correlates with AHI u Apnea-hypopnea Index (AHI): average number of apneas & – SLEEP 1991; 14(6):540-5 • Berlin 10 questions validated in primary care hypopneas per hour of sleep – Snoring, apnea, fatigue, sleepiness at wheel, Hypertension AHI < 5 is normal ● – Ann Intern Med. 1999 Oct 5;131(7):485-91 AHI 5-14 - Mild OSA ● • STOP-BANG used in Anesthesia AHI 15-29 - Moderate OSA ● – Snoring, Tired, Observed apnea, Pressure (HTN), BMI 35, Age 50, AHI >= 30 - Severe OSA ● Neck circumference 40 cm (15.75 inches), Gender (male) Wisconsin Sleep Cohort: prevalence of 2% women and 4% in men based on ● – Arch Otolaryngol Head Neck Surg. 2010 Oct: 136(10):1020-4 AHI > 5 and symptoms of daytime sleepiness; NEJM 1993; 328(17):1230-5. CLINICAL PREDICTORS OF EPWORTH SLEEPINESS SCALE https://www.slhn.org/docs/pdf/neuro-epworthsleepscale.pdf OSA Score < 10 is normal; 10-15 is situational sleepiness; 15 > excessive http://www.stopbang.ca/osa/screening.php • STOPBANG – 8 Questions • High risk: yes to 5-8 questions; Medium risk yes on 3-4;Low risk yes on 0-2 • Snoring • Tired (fatigue) • Observed Apnea • Pressure (Hypertension) • BMI >35 ( ≥ 30 is considered obese) • Age >50 • Neck size > 17 inches for men or >16 inches for women • Gender male 2

  3. PREVALENCE OF SLEEP APNEA COMPARISON OF QUESTIONNAIRES GE Silva et al. J Clin Sleep Med. 2011; 7(5): 467–472 u 602 working subjects, age 30-60, studied by overnight polysomnography u Obstructive sleep apnea defined as both AHI > 5 and hypersomnolence u 9% of women had AHI >5; 22% c/o hypersomnolence; yields 2% prevalence u 24% of men had AHI >5; 15% c/o hypersomnolence; yields 4% prevalence T Young; NEJM 1993;328:1230-5 CPAP as Secondary Prevention of Cumulative Percentage of Cardiovascular Events in OSA New Fatal (A) & non-Fatal (B) • Randomized trial CPAP v usual care; n=2717 Cardiovascular Events • Age 61; 80% men; AHI 29; BMI 28 JM Marin et al. Lancet. 2005 Mar • Pre -existing CAD or cerebrovascular disease 16;365(9464):1046-53 • Mean f/u 3.7 years; CPAP use 3.3 hrs KEY POINTS: • No change in primary cardiovascular outcomes 1. Increased mortality seen if AHI>30 • CPAP did improve quality of life measures – McEvoy RD et al. NEJM 2016;375:919 -931 2. CPAP reduced this risk 3

  4. OSA TREATMENT CPAP to Prevent Cardiovascular Events u Weight loss (10% weight loss reduces AHI 25%) u Avoid alcohol for 3+ hour before bed u Postural training (side sleeping since apnea worse on back) u Nasal patency (treat allergies) u CPAP (including autoCPAP; Bi-level less common) u Oral (dental) appliances u ENT surgery: u Tonsillectomy in kids u UPPP in adults <50% success u Hypoglossal nerve stimulator now FDA approved u Nasal expiratory resistor (Provent) u Nasal adhesive micro-valve resistor – delivers approx 5 cm pressure • McEvoy RD et al. NEJM 2016;375:919-931 WHY TREAT SLEEP APNEA? MANDIBULAR ADVANCEMENT DEVICES Advancement of mandible Enlarge airway behind tongue, but may also enlarge airway behind palate • Improve patient’s daytime alertness (big motivator!) • Reduce cardio- vascular risk – Still debated • Improve partner’s sleep 4

  5. ORAL APPLIANCE THERAPY: WHEN TO USE ORAL APPLIANCES? ANTERIOR MANDIBULAR • Mild to moderate OSA (AHI <30) REPOSITIONING • Intolerant of CPAP • After failed UPPP • Significant overbite • Must have teeth! • Relative contraindications: – Severe OSA with severe oxygen desaturation – TMJ symptoms Ferguson;Chest 1996;109:1269-75 CPAP: Nasal Mask or Pillows CPAP – Site Non-specific 5

  6. LONGTERM USE OF CPAP SURGICAL THERAPY Best compliance if AHI >30 & ESS >10 (primarily if non-compliant with CPAP) Nasal Surgery • Tonsillectomy: if 3-4++, can be 80-90% success • (common approach in kids) Uvulopalatopharyngoplasty (UPPP) reduces AHI by • 50% in 40-50% of patients • For snoring: laser or radiofrequency Mandibular advancement • – Genioglossus advancement with hyoid – Mandibular-maxillary osteotomy & advancement Hypoglossal Nerve Stimulator • Tracheotomy remains gold standard • McArdle N et al. AJRCCM 1999;159:1108-1114 Question 2 Question 1 • Which of the following is NOT part of • Based on sleep deprivation data, when do STOPBANG? shorter sleep hours cause more symptoms? – A. BMI • A. ≤ 8 hours – B. Alcohol • B. ≤ 7 hours – C. Hypertension • C. ≤ 6 hours • D. ≤ 4 hours – D. Observed apnea 6

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend